A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Peking University First Hospital ( Site 0009), Beijing

Peking University People's Hospital-Hematology ( Site 0033), Beijing

The 2nd Affiliated Hospital of Dalian Medical University ( Site 0019), Dalian

The First Hospital of Jilin University-Hematology ( Site 0023), Changchun

Shanghai General Hospital ( Site 0018), Shanghai

The First Affiliated Hospital of Soochow University-hematology department ( Site 0029), Suzhou

The Affiliated Hospital of Xuzhou Medical College ( Site 0022), Xuzhou

Anhui Provincial Hospital ( Site 0024), Hefei

Institute of hematology&blood disease hospital-Hematology ( Site 0030), Tianjin

The First Affiliated Hospital, Zhejiang University ( Site 0025), Hangzhou

The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 0021), Nanchang

The Second Affiliated Hospital of Third Military Medical University-Oncology Department ( Site 0002), Chongqing

Southwest Hospital of Third Military Medical University ( Site 0005), Chongqing

The Second Affiliated Hospital Chongqing Medical University ( Site 0013), Chongqing

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 0028), Wuhan

Tongji Hospital Tongji Medical,Science & Technology ( Site 0032), Wuhan

Guangzhou First People's Hospital-Hematology Department ( Site 0001), Guangzhou

Southern Medical University Nanfang Hospital ( Site 0003), Guangzhou

Shenzhen Second People's Hospital-Hematology Department ( Site 0006), Shenzhen

West China Hospital, Sichuan University ( Site 0008), Chengdu

The General Hospital of Western Theater Command ( Site 0007), Chengdu